The small molecule raptinal can simultaneously induce apoptosis and inhibit PANX1 activity

Santavanond, JP; Chiu, YH; Tixeira, R; LIU, Z; Yap, JKY; Chen, KW; Li, CL; Lu, YR; Roncero-Carol, J; Hoijman, E; Rutter, SF; Shi, B; Ryan, GF; Hodge, AL; Caruso, S; Baxter, AA; Ozkocak, DC; Johnson, C; Day, ZI; Mayfosh, AJ; Hulett, MD; Phan, TK; Atkin-Smith, GK; Poon, IKH

Author(s): Santavanond, JP; Chiu, YH; Tixeira, R; LIU, Z; Yap, JKY; Chen, KW; Li, CL; Lu, YR; Roncero-Carol, J; Hoijman, E; Rutter, SF; Shi, B; Ryan, GF; Hodge, AL; Caruso, S; Baxter, AA; Ozkocak, DC; Johnson, C; Day, ZI; Mayfosh, AJ; Hulett, MD; Phan, TK; Atkin-Smith, GK; Poon, IKH;
Details: Publication Year 2024-02-09,Volume 15,Issue #2,Page 123
Journal Title: Cell Death & Disease
Abstract: Discovery of new small molecules that can activate distinct programmed cell death pathway is of significant interest as a research tool and for the development of novel therapeutics for pathological conditions such as cancer and infectious diseases. The small molecule raptinal was discovered as a pro-apoptotic compound that can rapidly trigger apoptosis by promoting the release of cytochrome c from the mitochondria and subsequently activating the intrinsic apoptotic pathway. As raptinal is very effective at inducing apoptosis in a variety of different cell types in vitro and in vivo, it has been used in many studies investigating cell death as well as the clearance of dying cells. While examining raptinal as an apoptosis inducer, we unexpectedly identified that in addition to its pro-apoptotic activities, raptinal can also inhibit the activity of caspase-activated Pannexin 1 (PANX1), a ubiquitously expressed transmembrane channel that regulates many cell death-associated processes. By implementing numerous biochemical, cell biological and electrophysiological approaches, we discovered that raptinal can simultaneously induce apoptosis and inhibit PANX1 activity. Surprisingly, raptinal was found to inhibit cleavage-activated PANX1 via a mechanism distinct to other well-described PANX1 inhibitors such as carbenoxolone and trovafloxacin. Furthermore, raptinal also interfered with PANX1-regulated apoptotic processes including the release of the 'find-me' signal ATP, the formation of apoptotic cell-derived extracellular vesicles, as well as NLRP3 inflammasome activation. Taken together, these data identify raptinal as the first compound that can simultaneously induce apoptosis and inhibit PANX1 channels. This has broad implications for the use of raptinal in cell death studies as well as in the development new PANX1 inhibitors.
Publisher: Springer Nature
Research Division(s): Inflammation
PubMed ID: 38336804
Publisher's Version: https://doi.org/10.1038/s41419-024-06513-z
Open Access at Publisher's Site: https://doi.org/10.1038/s41419-024-06513-z
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2024-02-29 09:02:00

Last Modified: 2024-02-29 09:13:15